Advance education and support scientific research on
radical remissions from cancer
At the Radical Remission® Foundation we serve everyone who has ever heard the words “You have cancer,” and the loved ones who support them on their healing journeys.
A Harvard pilot research study shows that our Radical Remission® workshops led to a 7.7% improvement in overall quality of life after one month, which increased to 10.8% after six months.
Results indicate that integrating the Radical Remission® workshops into standard cancer care may improve patient well-being, potentially leading to better health outcomes and lower healthcare costs.
Your donation will support the next step in our research, a randomized controlled trial (RCT), as well as provide workshop scholarships to cancer patients in need of financial support.
What is a radical remission?
A radical remission is a cancer remission that occurs either without conventional medical treatment, after conventional medical treatment has failed, or when conventional and complementary methods are used in conjunction to overcome a dire prognosis.
We believe that, given enough documented cases to research, the cause(s) of radical remissions can be uncovered.
Harvard Publishes Results on Radical Remission® Study
The Harvard research results, published in the 2024;23 issue of Integrative Cancer Therapies found that participants in the Radical Remission® Multimodal Intervention (RRMI) workshops showed a 7.7% improvement in overall quality of life after 1 month, increasing to 10.8% after 6 months, as measured by the Functional Assessment of Chronic Illness Therapy—Spiritual Well-Being Scale (FACIT-Sp). This benefit was seen across demographics, including gender, ethnicity, BMI, and age. Dr. Kelly A. Turner's research on Radical Remission® survivors informed the RRMI.
"This pilot study provides supporting evidence to the scientific community that simple lifestyle changes can be taught to cancer patients in a short and effective way that leads to positive effects on their quality of life, lasting at least 6 months," said lead author Junaidah Barnett of Harvard.
The Radical Remission workshop, available in-person or online, covers mental, emotional, spiritual and physical aspects of healing. No matter which type of workshop was attended, comparable results were found, which means anyone anywhere can benefit from a Radical Remission® workshop.
"While the overall results are positive and promising, a larger randomized controlled trial would be invaluable for verifying these findings and identifying the subgroups that benefit most," said senior author Wei Wang of Brigham and Women's Hospital and Harvard Medical School. Junaidah Barnett added, "Such a trial would not only assess the impact of the workshops on the quality of life of cancer patients, but also its effects on cancer biomarkers".
“In my experience, people living with cancer always appreciate learning things they can do for themselves to improve their health and well-being,” said Michelle Holmes of the Department of Epidemiology, Harvard T.H. Chan School of Public Health, and Department of Medicine, Brigham and Women’s Hospital, also the manuscript's senior author.
Donate to Support Radical Remission® Foundation
Your donation will support the next step, which will be a randomized controlled trial (RCT). Your donations to our 501c3 non- profit organization, The Radical Remission® Foundation, are fully tax-deductible.
In addition to supporting radical remission research, our Foundation also offers scholarships to those in need of financial support in order to participate in a Radical Remission® Workshop. We believe that our curriculum should be accessible to everyone who needs it.
Become a Foundation Board Member
The Radical Remission® Foundation is seeking new members for its Board of Directors. If you are passionate, engaged, and committed to our mission, and bring a mix of skills, experience, and a willingness to contribute your time, talent, and resources, we welcome you to connect with us here.
About The Foundation
The Radical Remission® Foundation was founded by Kelly Turner, PhD, author of the New York Times bestseller Radical Remission®, along with a Board of Directors, in order to promote further scientific research on radical remission cases, in the hopes of deepening our understanding of cancer etiology, prevention, and remission. To learn more about Kelly’s work at the Radical Remission® Project, including related books, docuseries, films, and more, please visit www.radicalremission.com.
The Radical Remission® Foundation is a 501(c)3 non-profit organization in the state of New York. Our federal tax ID number is 82-4453041, and your donations are fully tax-deductible.
Dr. Kelly A. Turner
Researcher, Author and Founder of Radical Remission® Project
Kelly A. Turner, PhD is the New York Times bestselling author of Radical Remission and Radical Hope, now in 22 languages, which summarize her research into radical remissions – when someone heals from cancer or another serious illness in a statistically unlikely way, such as without conventional medicine or after conventional medicine has failed.
Over the past fifteen+ years, she has conducted research in 10 different countries and analyzed over 1,500 cases of radical remission. She holds a B.A. from Harvard University and a Ph.D. from the University of California, Berkeley.
Dr. Turner created and directed the 10-episode Radical Remission Docuseries that explores each of the 10 healing factors from the research and features many of the Radical Remission survivors from the books.
She is also the founder of the Radical Remission Project offering online courses, in-person workshops, private and group health coaching, the Radical Remission Project "Stories That Heal" Podcast, as well as, trains practitioners how to incorporate the 10 healing factors into their work.
The Harvard Research Team
Dr. Michelle Holmes is the Principal Investigator of the Radical Remission® Multimodal Intervention Study. She is an associate professor of medicine at Harvard Medical School and an associate professor in the department of Epidemiology at Harvard School of Public Health. Her research interests include lifestyle factors (diet, weight change, physical activity, and psychosocial factors, common medications like aspirin) affecting quality of life and survival after a cancer diagnosis, as well as the association between diet and breast cancer risk.
She co-edited a book on nutrition for cancer survivors published by the American Cancer Society. She has worked with the Nurses’ Health Study since 1997.
Since 2015 she is the co-Principal Investigator of the Aspirin for Breast Cancer Trial (abctrial.org), testing whether treating breast cancer patients with aspirin will prevent their breast cancer from recurring.
Dr. Junaidah Barnett is the co-Principal Investigator of the Radical Remission® Multimodal Intervention Study. She is currently affiliated with the Harvard School of Public Health, Department of Nutrition. Dr. Barnett’s research interests include determining the impact of diet, lifestyle, the environment, and other factors, on maintenance of optimal health, prevention of diseases, and optimization of healing from diseases.
As Principal Investigator/Project Director and/or co-Investigator, Dr. Barnett has successfully designed and conducted over 20 studies. Her research has focused on the associations of foods, food groups, dietary patterns, macro- and micro-nutrients, as well as other lifestyle factors, including physical activity, on various chronic and infectious diseases, and their risk factors.
As Principal Investigator, Dr. Barnett is currently evaluating the effect of the Nutrition Intervention Program of the Hebrew Senior Life Healthy Living Center of Excellence (HLCE) on the quality of life and dietary intake of participants.